14.31BMarket Cap
33.26P/E TTM
Ascendis Pharma A/S's Company Valuation
Currency: USD Updated: 2026-06-18The current valuation score of Ascendis Pharma A/S is 7.47, ranking 230 out of 389 in the Biotechnology & Medical Research industry. Its current P/E ratio is 33.26, which is 7.23% below the recent high of 35.66 and 331.01% above the recent low of -76.84.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.

Relevant data have not been disclosed by the company yet.